<DOC>
	<DOCNO>NCT00952159</DOCNO>
	<brief_summary>Many method detect CYP2D6 poor metabolizers validate . Some base phenotyping ( metabolism dextromethorphan debrisoquine ) others genotyping . Up , CYP2D6 pharmacogenetics restrict field research , spite poor metabolizer profile concern 5 10 % caucasian population . Nevertheless , polymorphism CYP2D6 responsible metabolism many drug , particularly two opioids involve pain management : codeine tramadol , metabolites represent effective part drug effect . So prescribing codeine tramadol patient poor metabolizer CYP2D6 likely ineffective pain management . O-demethyl-tramadol , metabolite tramadol via CYP2D6 , important consider analgesic effect 2 4 time potent tramadol . The investigator propose phenotype CYP2D6 post-operative patient treat tramadol monitoring seric concentration O-demethyl tramadol tramadol make ratio comparison genotype , find threshold determine poor metabolizers . As already describe , genotyping CYP2D6 use rapid detection method allele implicate poor metabolizer status ( CYP2D6*3 , *4 , *5 et *6 ) Caucasian population . Sampling execute two time ( H24 H48 surgery ) blood ( three EDTA tube ) post-operative monitoring patient . This study likely include 320 post-operative patient treat intravenous tramadol one year three university hospital center ( CHU Caen , Creteil Rouen ) . The first aim study validation monitor seric concentration O-demethyl-tramadol tramadol make ratio order detect CYP2D6 poor metabolizers therapeutic situation , compare result genotyping . The finding poor metabolizer status patient make choice analgesic drug easier , avoid tramadol codeine . The final objective research able determine CYP2D6 phenotype patient treat tramadol without good analgesia . By single take blood rapid response , method like improve pain management . Furthermore , CYP2D6 phenotyping interesting patient many drug depend way metabolism .</brief_summary>
	<brief_title>CYTRAM ( Cytochrome P450 , Tramadol )</brief_title>
	<detailed_description />
	<mesh_term>Tramadol</mesh_term>
	<criteria>age &gt; 18 year , postoperative patient treat intravenous tramadol Caucasian origin take blood H24 H48 postoperative monitoring patient already include study patient take opioid drug surgery patient take one drug inhibit CYP2D6 surgery pregnancy breast feeding patient one contraindication take tramadol postoperative analgesia hepatocellular incapacity ( TP &lt; 70 % )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>tramadol</keyword>
	<keyword>CYP2D6</keyword>
	<keyword>O-demethyl-tramadol</keyword>
	<keyword>poor metabolizer</keyword>
	<keyword>genotyping</keyword>
	<keyword>phenotyping</keyword>
</DOC>